Januvia patient support programme
Numark and Merck Sharp & Dohme have launched a patient support programme for type 2 diabetes patients who are prescribed Januvia (sitagliptin). The programme provides Numark members with the tools, skills and knowledge required to confidently perform interventions with their patients. Advice on diet, exercise and general lifestyle is also provided as part of the message. The programme is available from the Numark website.
Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2014.20067099
Recommended from Pharmaceutical Press